Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Assertio Therapeutics Inc (ASRT)

Assertio Therapeutics Inc (ASRT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 75,592
  • Shares Outstanding, K 95,000
  • Annual Sales, $ 152,070 K
  • Annual Income, $ -331,940 K
  • 60-Month Beta 0.96
  • Price/Sales 0.51
  • Price/Cash Flow 1.19
  • Price/Book 0.60
Trade ASRT with:
  • Price/Earnings ttm 6.26
  • Earnings Per Share ttm 0.13
  • Most Recent Earnings $0.11 on 03/11/24
  • Latest Earnings Date 05/14/24
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 183.73% ( +138.78%)
  • Historical Volatility 59.23%
  • IV Percentile 95%
  • IV Rank 35.03%
  • IV High 459.08% on 02/01/24
  • IV Low 35.26% on 12/26/23
  • Put/Call Vol Ratio 2.31
  • Today's Volume 43
  • Volume Avg (30-Day) 383
  • Put/Call OI Ratio 0.24
  • Today's Open Interest 27,245
  • Open Int (30-Day) 24,720

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.01
  • Number of Estimates 1
  • High Estimate -0.01
  • Low Estimate -0.01
  • Prior Year -0.07
  • Growth Rate Est. (year over year) +85.71%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7620 +2.36%
on 04/17/24
1.1300 -30.97%
on 03/18/24
-0.3400 (-30.36%)
since 03/15/24
3-Month
0.7620 +2.36%
on 04/17/24
1.2100 -35.54%
on 03/12/24
-0.1003 (-11.39%)
since 01/17/24
52-Week
0.7620 +2.36%
on 04/17/24
8.0100 -90.26%
on 05/11/23
-5.4300 (-87.44%)
since 04/17/23

Most Recent Stories

More News
IMPORTANT ALERT: Halper Sadeh LLC Investigates FOCS, ASRT, MDWT, SPPI

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

FOCS : 52.99 (-0.02%)
ASRT : 0.7800 (-1.97%)
MDWT : 26.99 (unch)
SPPI : 1.0300 (unch)
Assertio (ASRT) Reports Q1 Loss, Tops Revenue Estimates

Assertio (ASRT) delivered earnings and revenue surprises of -153.85% and 12.40%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?

ASRT : 0.7800 (-1.97%)
MEIP : 3.31 (+3.44%)
SHAREHOLDER ALERT: Weiss Law Reminds SPPI, NATI, CCFN, and ARST Shareholders About Its Ongoing Investigations

/PRNewswire/ -- If you own shares in any of the companies listed above and would like to discuss our investigations or have any questions concerning this...

SPPI : 1.0300 (unch)
NATI : 59.98 (unch)
ASRT : 0.7800 (-1.97%)
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SHBI, CBIO, TA, ASRT

/PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...

SHBI : 10.08 (-0.88%)
CBIO : 7.6695 (-2.65%)
TA : 86.00 (-0.01%)
ASRT : 0.7800 (-1.97%)
SHAREHOLDER ALERT: Weiss Law Investigates Spectrum Pharmaceuticals, Inc.

/PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Spectrum...

SPPI : 1.0300 (unch)
ASRT : 0.7800 (-1.97%)
SHAREHOLDER ALERT: Weiss Law Investigates Assertio Holdings, Inc.

/PRNewswire/ -- Weiss Law is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Assertio Holdings, Inc....

ASRT : 0.7800 (-1.97%)
SPPI : 1.0300 (unch)
Assertio (ASRT) Gains But Lags Market: What You Should Know

In the latest trading session, Assertio (ASRT) closed at $5.08, marking a +1.6% move from the previous day.

ASRT : 0.7800 (-1.97%)
SPECTRUM PHARMACEUTICALS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Spectrum Pharmaceuticals, Inc. - SPPI

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Spectrum Pharmaceuticals, Inc. (NasdaqGS: SPPI)...

SPPI : 1.0300 (unch)
ASRT : 0.7800 (-1.97%)
ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Spectrum Pharmaceuticals, Inc.

/PRNewswire/ -- Rowley Law PLLC is investigating potential securities law violations by Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) and its board of...

SPPI : 1.0300 (unch)
ASRT : 0.7800 (-1.97%)
ASRT Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Assertio Holdings, Inc. Is Fair to Shareholders

Halper Sadeh LLC, an investor rights law firm, is investigating whether the merger of Assertio Holdings, Inc. (NASDAQ: ASRT) and Spectrum Pharmaceuticals, Inc. is fair to Assertio shareholders.

ASRT : 0.7800 (-1.97%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is in highly oversold territory. Beware of a trend reversal.

See More Share

Business Summary

Assertio Holdings Inc. is a specialty pharmaceutical company. Its portfolio consists of branded prescription neurology, inflammation and pain medications. The company's business development includes acquisitions, licensing and mergers. Assertio Holdings Inc., formerly known as Assertio Therapeutics Inc.,...

See More

Key Turning Points

3rd Resistance Point 0.8705
2nd Resistance Point 0.8452
1st Resistance Point 0.8126
Last Price 0.7800
1st Support Level 0.7547
2nd Support Level 0.7294
3rd Support Level 0.6968

See More

52-Week High 8.0100
Fibonacci 61.8% 5.2413
Fibonacci 50% 4.3860
Fibonacci 38.2% 3.5307
Last Price 0.7800
52-Week Low 0.7620

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar